IGF2 and early-onset autosomal dominant Alzheimer disease: Furthermore, increasing IGF2 levels in the hippocampus of Alzheimer’s disease model mice rescues cognitive, cellular and synaptic impairments, suggesting that IGF2 might represent a target for regulating cognitive functions in neuropsychiatric diseases [19, 20].